Johnson & Johnson Cordis Corporation Unit Cuts Jobs as Cypher Stent Suffers, Merges Two Separate Cordis Unit Sales Staffs

Published: Feb 11, 2011

NEW YORK, Feb 10 (Reuters) - Johnson & Johnson said its Cordis medical devices unit, whose sales have fallen sharply in recent years due to waning demand for its Cypher heart stent, will lay off an unspecified number of salespeople and merge two separate sales forces within the division.

Back to news